Advaxis, Inc. (ADXS) News https://www.advaxiscompany.xyz/news/rss The latest news released by Advaxis, Inc. (ADXS) en-us Equisolve Investor Relations Suite http://content.stockpr.com/advaxis/files/adxs_logo.png https://www.advaxiscompany.xyz Advaxis to Present at the Aegis Annual Growth Conference https://www.advaxiscompany.xyz/news/detail/1239/advaxis-to-present-at-the-aegis-annual-growth-conference Mon, 19 Sep 16 16:30:00 -0400 Advaxis Unveils State-of-the-art Manufacturing Facility, Laboratory to Produce and Develop Novel Immuno-Oncology Therapeutics https://www.advaxiscompany.xyz/news/detail/1238/advaxis-unveils-state-of-the-art-manufacturing-facility-laboratory-to-produce-and-develop-novel-immuno-oncology-therapeutics Mon, 12 Sep 16 08:00:00 -0400 N.J. Gov. Christie to Attend Advaxis Ribbon Cutting for New Manufacturing/Laboratory Facility in Princeton https://www.advaxiscompany.xyz/news/detail/1237/n-j-gov-christie-to-attend-advaxis-ribbon-cutting-for-new-manufacturinglaboratory-facility-in-princeton Thu, 08 Sep 16 14:28:00 -0400 Advaxis to Present at Rodman & Renshaw 18th Annual Global Investment Conference https://www.advaxiscompany.xyz/news/detail/1236/advaxis-to-present-at-rodman-renshaw-18th-annual-global-investment-conference Tue, 06 Sep 16 08:00:00 -0400 Advaxis to Participate in Cervivor School https://www.advaxiscompany.xyz/news/detail/1235/advaxis-to-participate-in-cervivor-school Fri, 19 Aug 16 08:00:00 -0400 Advaxis Secures a $30M Direct Placement Financing to Healthcare Specialist Investors https://www.advaxiscompany.xyz/news/detail/1234/advaxis-secures-a-30m-direct-placement-financing-to-healthcare-specialist-investors Tue, 16 Aug 16 09:32:00 -0400 Advaxis Announces that Phase 2 Head and Neck Cancer Study with AXAL Advances to Second Stage https://www.advaxiscompany.xyz/news/detail/1233/advaxis-announces-that-phase-2-head-and-neck-cancer-study-with-axal-advances-to-second-stage Thu, 11 Aug 16 08:00:00 -0400 Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration https://www.advaxiscompany.xyz/news/detail/1232/amgen-and-advaxis-enter-global-cancer-immunotherapies-collaboration Tue, 02 Aug 16 08:00:00 -0400 Phase 1/2 Combination Trial of AXAL and Durvalumab Completes Second Dose-Escalation Cohort https://www.advaxiscompany.xyz/news/detail/1231/phase-12-combination-trial-of-axal-and-durvalumab-completes-second-dose-escalation-cohort Tue, 26 Jul 16 08:00:00 -0400 Advaxis’ AXAL Receives Fast Track Designation by the FDA as Adjuvant Therapy for High-Risk Locally Advanced Cervical Cancer Patients https://www.advaxiscompany.xyz/news/detail/1230/advaxis-axal-receives-fast-track-designation-by-the-fda-as-adjuvant-therapy-for-high-risk-locally-advanced-cervical-cancer-patients Thu, 21 Jul 16 07:00:00 -0400 European Medicines Agency Committee Classifies Advaxis’ Axalimogene Filolisbac as an Advanced-Therapy Medicinal Product https://www.advaxiscompany.xyz/news/detail/1229/european-medicines-agency-committee-classifies-advaxis-axalimogene-filolisbac-as-an-advanced-therapy-medicinal-product Mon, 18 Jul 16 07:30:00 -0400 Advaxis Appoints Ranya Dajani as Vice President, Corporate Development https://www.advaxiscompany.xyz/news/detail/1228/advaxis-appoints-ranya-dajani-as-vice-president-corporate-development Tue, 12 Jul 16 08:00:00 -0400 Advaxis to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference https://www.advaxiscompany.xyz/news/detail/1227/advaxis-to-present-at-cantor-fitzgeralds-2nd-annual-healthcare-conference Fri, 08 Jul 16 08:00:00 -0400 FDA Grants Special Protocol Assessment to Advaxis’ Phase 3 Study of AXAL in Patients with Cervical Cancer https://www.advaxiscompany.xyz/news/detail/1226/fda-grants-special-protocol-assessment-to-advaxis-phase-3-study-of-axal-in-patients-with-cervical-cancer Wed, 06 Jul 16 07:00:00 -0400 Advaxis to Webcast Investor & Analyst Day 2016 https://www.advaxiscompany.xyz/news/detail/1225/advaxis-to-webcast-investor-analyst-day-2016 Mon, 27 Jun 16 08:00:00 -0400 Advaxis Announces First Patient Dosed in Phase 2 Trial Evaluating AXAL in Anal Cancer https://www.advaxiscompany.xyz/news/detail/1224/advaxis-announces-first-patient-dosed-in-phase-2-trial-evaluating-axal-in-anal-cancer Wed, 08 Jun 16 08:00:00 -0400 Advaxis Announces Updated Data at ASCO from a Phase 2 Study of AXAL in Advanced Cervical Cancer Showing Promising Survival Rates Consistent with Earlier Reports https://www.advaxiscompany.xyz/news/detail/1223/advaxis-announces-updated-data-at-asco-from-a-phase-2-study-of-axal-in-advanced-cervical-cancer-showing-promising-survival-rates-consistent-with-earlier-reports Mon, 06 Jun 16 07:00:00 -0400 Advaxis to Host Investor & Analyst Day on June 28, 2016 https://www.advaxiscompany.xyz/news/detail/1222/advaxis-to-host-investor-analyst-day-on-june-28-2016 Tue, 17 May 16 08:05:00 -0400 UPDATE – Advaxis to Present at Jefferies 2016 Healthcare Conference https://www.advaxiscompany.xyz/news/detail/1221/update-advaxis-to-present-at-jefferies-2016-healthcare-conference Thu, 05 May 16 09:25:00 -0400 FDA Grants Advaxis Fast Track Designation for ADXS-HER2 for Patients with Newly-Diagnosed, Non-Metastatic, Surgically-Resectable Osteosarcoma https://www.advaxiscompany.xyz/news/detail/1219/fda-grants-advaxis-fast-track-designation-for-adxs-her2-for-patients-with-newly-diagnosed-non-metastatic-surgically-resectable-osteosarcoma Thu, 28 Apr 16 07:05:00 -0400